Trials / Completed
CompletedNCT01678781
Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide
Open International Study on Quality of Life in IBS Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 607 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate, by country and overall, the changes from baseline of the irritable bowel syndrome quality of life (IBS QoL) total score after 4 and 8 weeks of treatment with Duspatalin® or Dicetel® in IBS patients.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2012-09-05
- Last updated
- 2013-09-09
Locations
24 sites across 4 countries: China, Egypt, Mexico, Poland
Source: ClinicalTrials.gov record NCT01678781. Inclusion in this directory is not an endorsement.